PHK
VNDA icon

Point72 Hong Kong’s Vanda Pharmaceuticals VNDA Stock Holding History

Point72 Hong Kong’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,416
Closed -$15K – 2453
2022
Q2 		$15K Buy
1,416
+692
+96% +$7.17K ﹤0.01% 1618
2022
Q1 		$8K Sell
724
-28
-4% -$368 ﹤0.01% 1634
2021
Q4 		$12K Buy
752
+41
+6% +$714 ﹤0.01% 1618
2021
Q3 		$12K Buy
+711
New +$12.5K ﹤0.01% 1780
2020
Q3 		– Sell
-593
Closed -$7K – 1560
2020
Q2 		$7K Sell
593
-471
-44% -$5.33K ﹤0.01% 1019
2020
Q1 		$11K Buy
+1,064
New +$13.2K ﹤0.01% 670
2019
Q3 		– Sell
-58
Closed -$1K – 1373
2019
Q2 		$1K Sell
58
-926
-94% -$14.7K ﹤0.01% 1061
2019
Q1 		$18K Buy
+984
New +$22.4K 0.01% 695
2018
Q1 		– Sell
-120
Closed -$2K – 1175
2017
Q4 		$2K Buy
120
+61
+103% +$905 ﹤0.01% 716
2017
Q3 		$1K Buy
59
+10
+20% +$167 ﹤0.01% 734
2017
Q2 		$1K Buy
+49
New +$706 ﹤0.01% 742
2017
Q1 		– Sell
-216
Closed -$3K – 1010
2016
Q4 		$3K Buy
+216
New +$3.47K ﹤0.01% 760

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Point72 Hong Kong's VNDA Position: Q3 2022 in Review

Point72 Hong Kong sold out of Vanda Pharmaceuticals (VNDA) in Q3 2022, closing a stake of 1,416 shares — an estimated $15K sold.

Point72 Hong Kong first reported a position in VNDA in Q4 2016 and held it in 12 quarters. The position peaked at $18K in Q1 2019. 178 funds tracked by Wall St. Rank hold VNDA as of Q3 2022.

  • Point72 Hong Kong reported no remaining Vanda Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Point72 Hong Kong sold 1,416 Vanda Pharmaceuticals shares in Q3 2022, an estimated $15K.
  • Point72 Hong Kong first reported a position in Vanda Pharmaceuticals in Q4 2016 and held it in 12 quarters.
  • Point72 Hong Kong's Vanda Pharmaceuticals position peaked at $18K in Q1 2019.
  • 178 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2022.

Based on Point72 Hong Kong's 13F filing for Q3 2022, filed 14 Nov 2022.